España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
GB Sciences
GBLX
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.00370
0.00
0.00%
At close: -
$0.00500
0.00130
35.14%
After Hours: Nov 22, 8:46 AM EDT
Get Report
Comment
GB Sciences (GBLX) Forecast
News
Earnings
GB Sciences (GBLX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for GB Sciences (OTC:GBLX) Stock
GB Sciences Stock (OTC: GBLX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 27, 2024
Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday
Patricio Liddle
Tuesday, November 01, 2022
Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study
Joana Scopel
Monday, October 10, 2022
New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids
Jelena Martinovic
Tuesday, April 12, 2022
Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease
Vuk Zdinjak
Tuesday, March 29, 2022
Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes
Nina Zdinjak
Tuesday, February 01, 2022
Not So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers Clarify
Nina Zdinjak
Friday, January 14, 2022
The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More
Javier Hasse
Tuesday, January 11, 2022
Gb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industry
Jelena Martinovic
Thursday, April 09, 2020
A Snapshot Of America's Medical Marijuana Markets: Louisiana
Andrew Ward
Thursday, November 14, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Wednesday, November 13, 2019
Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin
Tuesday, November 12, 2019
Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin
Friday, November 08, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Thursday, November 07, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
Friday, October 25, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
Wednesday, October 23, 2019
Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin
Tuesday, October 15, 2019
Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin
Sunday, March 31, 2019
The Week In Cannabis: SAFE(er) Banking, New Jersey, Seth Rogen, Walgreens And Earnings
Javier Hasse
Saturday, March 23, 2019
The Week In Cannabis: SAFE Banking Act, Stocks In Red, IPOs, High Tech Agro Projects And Celebs In Marijuana
Javier Hasse
Monday, January 21, 2019
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Javier Hasse
Wednesday, October 03, 2018
GB Sciences And University of Athens Earlier ...
Benzinga Newsdesk
Monday, April 02, 2018
Pot Stocks, ETFs And Top News From The Cannabis Industry
Benzinga
Tuesday, July 18, 2017
Bigger Than Bingo: Seminole Chief Jim Billie On His New Cannabis Advisory Firm And A Tax-Free Environment
Benzinga
Monday, March 13, 2017
How To Pick The Right Marijuana Stocks
Benzinga
Friday, March 10, 2017
Marijuana Stocks: How CEOs Can Navigate Market Volatility (And Survive Spicer And Sessions)
Benzinga
